(Q44344629)

2 December 2017

Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist (English)

1 reference

2 December 2017

0 references

Gergen KA

1

1 reference

2 December 2017

Zadina JE

series ordinal

2

1 reference

2 December 2017

Paul D

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

316

1 reference

2 December 2017

33-38

1 reference

2 December 2017

1

1 reference

Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Intrathecal morphine in mice: a new technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Naloxonazine actions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Supraspinal mu 2-opioid receptors mediate spinal/supraspinal morphine synergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

The physiology and pharmacology of spinal opiates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900656-5

10.1016/S0014-2999(96)00656-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference